These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26051332)

  • 41. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
    Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
    Deraco M; Kusamura S; Laterza B; Favaro M; Fumagalli L; Costanzo P; Baratti D
    In Vivo; 2006; 20(6A):773-6. PubMed ID: 17203766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.
    Rauwerdink P; Brosens LAA; van Diepen KK; Ghedri ON; Kranenburg O; Boerma D; Witkamp AJ; van Grevenstein HMU
    World J Surg Oncol; 2022 May; 20(1):147. PubMed ID: 35538541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritonei.
    Flood MP; Kong JC; Pham T; Waters PS; Soucisse M; Ramsay R; Wong HL; Mitchell C; Michael M; McCormick JJ; Warrier SK; Akhurst T; Heriot AG
    Eur J Surg Oncol; 2022 Jul; 48(7):1606-1613. PubMed ID: 35148916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
    Hsu KH; Chou CY; Chang YC
    Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.
    Chua TC; Yan TD; Smigielski ME; Zhu KJ; Ng KM; Zhao J; Morris DL
    Ann Surg Oncol; 2009 Jul; 16(7):1903-11. PubMed ID: 19387742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.
    Järvinen P; Ristimäki A; Kantonen J; Lepistö A
    Scand J Surg; 2013; 102(3):145-51. PubMed ID: 23963027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
    Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.
    Dineen SP; Royal RE; Hughes MS; Sagebiel T; Bhosale P; Overman M; Matamoros A; Mansfield PF; Fournier KF
    Ann Surg Oncol; 2015 Oct; 22(11):3640-6. PubMed ID: 25698402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.
    Honoré C; Caruso F; Dartigues P; Benhaim L; Chirica M; Goéré D; Elias D
    Anticancer Res; 2015 Sep; 35(9):4943-7. PubMed ID: 26254392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification.
    Bhatt A; Mishra S; Prabhu R; Ramaswamy V; George A; Bhandare S; Shah M; Mehta S
    Eur J Surg Oncol; 2018 Jul; 44(7):1105-1111. PubMed ID: 29685759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme.
    Fish R; Renehan AG; Punnett G; Aziz O; Fulford P; Selvasekar C; Wilson M; Halstead R; O'Dwyer ST
    Colorectal Dis; 2018 Oct; 20(10):888-896. PubMed ID: 29920919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei.
    Delhorme JB; Honoré C; Benhaim L; Dumont F; Dartigues P; Dromain C; Ducreux M; Elias D; Goéré D
    Eur J Surg Oncol; 2017 Jan; 43(1):159-167. PubMed ID: 27646440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei.
    Cole KL; Choudry HA; Jones HL; Goodell PP; Bartlett DL
    J Surg Oncol; 2012 Sep; 106(4):513-6. PubMed ID: 22396067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Current treatment recommendations for pseudomyxoma peritonei].
    Leebmann H; Piso P
    Chirurgie (Heidelb); 2022 Dec; 93(12):1152-1157. PubMed ID: 36097078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytoreductive surgery plus bicavitary chemohyperthermia as treatment of pseudomixoma peritonei with pleural extension. A case report and review of the literature.
    Saladino E; Famulari C; La Monaca E; Fortugno A; Fleres F; Macrì A
    Ann Ital Chir; 2014; 85(4):372-6. PubMed ID: 25263588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mentored experience of establishing a national peritoneal malignancy programme - Experience of first 50 operative cases.
    Chang KH; Kazanowski M; Staunton O; Cahill RA; Moran BJ; Shields C; Mulsow J
    Eur J Surg Oncol; 2017 Feb; 43(2):395-400. PubMed ID: 27955836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treating pseudomyxoma peritonei without heated intraperitoneal chemotherapy--a first look in New Zealand.
    Wheeler BR; Reddy SK; Kenwright D; Keating JP
    N Z Med J; 2014 Feb; 127(1389):31-9. PubMed ID: 24548955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.